National Health Investors Inc

National Health Investors Inc(NHI)股票分析

$65.680

-0.768 (-1.17%)收盘时

Loading chart…
最高
66.000
开盘
66.000
成交量加权均价
65.55
成交量
225.88K
市值
2.93B
最低
64.975
成交额
14.81M
企业价值/息税折旧摊销前利润(TTM)
15.42

National Health Investors, Inc. is a real estate investment trust. The Company specializes in sales, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment consists of real estate investments, leases, and mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has over 176 healthcare real estate properties located in 32 states and leased primarily pursuant to triple-net leases to 31 tenants. The SHOP segment consists of two ventures that own the operations of independent living facilities. This segment has over 26 senior housing communities located in 13 states with a combined 3,009 units.

AI 分析 of National Health Investors Inc (NHI)

买入

National Health Investors Inc (NHI) appears to be a good buy right now due to its current price of $67.06, which is significantly below the analyst price targets of $79 and $80. The company has shown strong earnings growth with a 45.6% year-over-year increase in EPS to $1.15, indicating robust profitability. However, a risk to consider is the recent YTD change of -12.74%, which reflects market volatility.

分析师评级(12)

上行空间 +30.07%
持有
2 买入
9 持有
1 卖出
当前: 65.68
最低
77.00
平均
85.43
最高
90.00

Huntington

2026-09-10

目标价

$79

跑赢大盘

Huntington

2026-09-09

目标价

$79

跑赢大盘

Truist

2026-09-02

目标价

$80

买入

Wells Fargo

2026-09-01

目标价

$78

Equal Weight

BofA

2026-08-24

目标价

$86

买入

估值指标

National Health Investors Inc(NHI)当前预期市盈率为 18.15,5 年平均预期市盈率为 20.89。

预期市盈率

合理
5 年均值 P/E
20.89
当前P/E
18.15
高估
23.95
低估
17.84

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
14.92
当前EV/EBITDA
15.42
高估
16.25
低估
13.59

预期市销率

低估
5 年均值 P/S
8.59
当前P/S
6.69
高估
9.75
低估
7.44

Alphio AI 对 NHI 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%NHI

$74.94

情景价格

基

基准

基准 · 50%NHI

$72.59

情景价格

悲

悲观

悲观 · 25%NHI

$68.11

情景价格

持有 NHI 的大户

B

BNY Mellon ETF Investment Adviser, LLC

+ 持有NHI

+2.37%

3个月收益率

S

Sound Income Strategies, LLC

+ 持有NHI

-3.54%

3个月收益率

事件时间线

2026-10-01 (ET)

07:30:00

National Health Investors Invests $107.7M to Acquire Six Properties

2026-08-10 (ET)

16:30:00

NHI Reports Q2 Revenue of $121.32M, Beating Expectations

16:30:00

Company FY26 Guidance Includes $180M in New Investments

2026-07-27 (ET)

06:30:00

National Health Investors Appoints Chris Maingot as COO

2026-06-23 (ET)

20:30:00

Tech Stocks Plummet Due to Valuation Concerns

资讯

NHI 常见问题 —— 由 Alphio AI 解答

National Health Investors, Inc. is a real estate investment trust. The Company specializes in sales, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment consists of real estate investments, leases, and mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has over 176 healthcare real estate properties located in 32 states and leased primarily pursuant to triple-net leases to 31 tenants. The SHOP segment consists of two ventures that own the operations of independent living facilities. This segment has over 26 senior housing communities located in 13 states with a combined 3,009 units. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).

National Health Investors Inc (NHI) appears to be a good buy right now due to its current price of $67.06, which is significantly below the analyst price targets of $79 and $80. The company has shown strong earnings growth with a 45.6% year-over-year increase in EPS to $1.15, indicating robust profitability. However, a risk to consider is the recent YTD change of -12.74%, which reflects market volatility.

12 analysts cover NHI: 2 rate it Buy, 9 Hold and 1 Sell. The average price target is 85.43.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易